Cognitive mechanisms for processing nonwords: Evidence from Alzheimer's disease

被引:17
|
作者
Glosser, G
Friedman, RB
Kohn, SE
Sands, L
Grugan, P
机构
[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] Georgetown Univ, Georgetown Inst Cognit & Computat Sci, Dept Neurol, Washington, DC 20057 USA
[3] Moss Rehabil Res Inst, Philadelphia, PA USA
[4] Univ Calif San Francisco, Mt Zion Inst Aging, San Francisco, CA 94143 USA
[5] Clark Univ, Dept Psychol, Worcester, MA 01610 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1006/brln.1997.1924
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Repetition and reading of various types of pronounceable nonwords (pseudowords) was examined in patients with probable Alzheimer's disease (AD) and healthy elderly controls. Overall accuracy of performance was lower in AD patients compared to controls, but the two groups showed qualitatively similar response patterns when reading different kinds of pseudowords aloud and when repeating pseudowords composed of familiar phonological forms. analogous to those in real English words. AD patients diverged in performance from controls, however, when repeating pseudowords composed of phonologically unusual forms. These results support two conclusions: (1) Aspects of phonological processing may become disrupted in AD patients in association with increasing dementia severity, while orthographic processing remains comparatively less impaired. (2) The results are consistent with the view that the processing of pseudowords is achieved through the same system as real words, and further show that the influence of prior language experience on the processing of novel linguistic forms occurs primarily at the level of phonological, rather than orthographic processing. (C) 1998 Academic Press.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [41] The cognitive transition from normal aging to Alzheimer's disease
    Bäckman, L
    BRAIN AND COGNITION, 1999, 39 (01) : 5 - 6
  • [42] Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease
    Geifman, Nophar
    Brinton, Roberta Diaz
    Kennedy, Richard E.
    Schneider, Lon S.
    Butte, Atul J.
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [43] Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
    Nophar Geifman
    Roberta Diaz Brinton
    Richard E. Kennedy
    Lon S. Schneider
    Atul J. Butte
    Alzheimer's Research & Therapy, 9
  • [44] Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives
    Kamal, Mohammad A.
    Greig, Nigel H.
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (11) : 1138 - 1139
  • [45] Estrogen receptor β in Alzheimer's disease: From mechanisms to therapeutics
    Zhao, Liqin
    Woody, Sarah K.
    Chhibber, Anindit
    AGEING RESEARCH REVIEWS, 2015, 24 : 178 - 190
  • [46] Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease
    Chavez-Gutierrez, Lucia
    Szaruga, Maria
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 105 : 75 - 85
  • [47] Molecular mechanisms of Alzheimer's disease: From top to bottom
    Mello-Carpes, Pamela B.
    Inestrosa, Nibaldo C.
    Paula-Lima, Andrea Cristina
    FRONTIERS IN AGING, 2022, 3
  • [48] Cognitive rehabilitation in Alzheimer’s Disease
    Maria Cotelli
    Marco Calabria
    Orazio Zanetti
    Aging Clinical and Experimental Research, 2006, 18 : 141 - 143
  • [49] Cognitive training for Alzheimer's disease
    Poczatek, Gabriela
    Wyszomirska, Julia
    Segiet, Natalia
    AKTUALNOSCI NEUROLOGICZNE, 2023, 23 (04): : 138 - 144
  • [50] Cognitive Reserve and Alzheimer’s Disease
    Wei Xu
    Jin-Tai Yu
    Meng-Shan Tan
    Lan Tan
    Molecular Neurobiology, 2015, 51 : 187 - 208